rs2074900

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_001082.5(CYP4F2):​c.1029C>T​(p.His343His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.302 in 1,613,564 control chromosomes in the GnomAD database, including 75,671 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.27 ( 5765 hom., cov: 30)
Exomes 𝑓: 0.31 ( 69906 hom. )

Consequence

CYP4F2
NM_001082.5 synonymous

Scores

1
1

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 2.08

Publications

32 publications found
Variant links:
Genes affected
CYP4F2 (HGNC:2645): (cytochrome P450 family 4 subfamily F member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum. The enzyme starts the process of inactivating and degrading leukotriene B4, a potent mediator of inflammation. This gene is part of a cluster of cytochrome P450 genes on chromosome 19. Another member of this family, CYP4F11, is approximately 16 kb away. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (REVEL=0.015).
BP6
Variant 19-15886010-G-A is Benign according to our data. Variant chr19-15886010-G-A is described in ClinVar as Benign. ClinVar VariationId is 3056285.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.316 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP4F2NM_001082.5 linkc.1029C>T p.His343His synonymous_variant Exon 9 of 13 ENST00000221700.11 NP_001073.3 P78329-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP4F2ENST00000221700.11 linkc.1029C>T p.His343His synonymous_variant Exon 9 of 13 1 NM_001082.5 ENSP00000221700.3 P78329-1

Frequencies

GnomAD3 genomes
AF:
0.268
AC:
40703
AN:
151844
Hom.:
5769
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.186
Gnomad AMI
AF:
0.298
Gnomad AMR
AF:
0.262
Gnomad ASJ
AF:
0.253
Gnomad EAS
AF:
0.232
Gnomad SAS
AF:
0.264
Gnomad FIN
AF:
0.295
Gnomad MID
AF:
0.171
Gnomad NFE
AF:
0.319
Gnomad OTH
AF:
0.259
GnomAD2 exomes
AF:
0.283
AC:
70998
AN:
251290
AF XY:
0.284
show subpopulations
Gnomad AFR exome
AF:
0.182
Gnomad AMR exome
AF:
0.251
Gnomad ASJ exome
AF:
0.253
Gnomad EAS exome
AF:
0.245
Gnomad FIN exome
AF:
0.299
Gnomad NFE exome
AF:
0.318
Gnomad OTH exome
AF:
0.276
GnomAD4 exome
AF:
0.306
AC:
446849
AN:
1461602
Hom.:
69906
Cov.:
40
AF XY:
0.304
AC XY:
221366
AN XY:
727096
show subpopulations
African (AFR)
AF:
0.183
AC:
6125
AN:
33478
American (AMR)
AF:
0.255
AC:
11408
AN:
44698
Ashkenazi Jewish (ASJ)
AF:
0.250
AC:
6532
AN:
26128
East Asian (EAS)
AF:
0.205
AC:
8142
AN:
39680
South Asian (SAS)
AF:
0.262
AC:
22621
AN:
86228
European-Finnish (FIN)
AF:
0.306
AC:
16352
AN:
53398
Middle Eastern (MID)
AF:
0.215
AC:
1237
AN:
5758
European-Non Finnish (NFE)
AF:
0.321
AC:
356790
AN:
1111854
Other (OTH)
AF:
0.292
AC:
17642
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
20389
40779
61168
81558
101947
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11536
23072
34608
46144
57680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.268
AC:
40693
AN:
151962
Hom.:
5765
Cov.:
30
AF XY:
0.265
AC XY:
19659
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.185
AC:
7684
AN:
41460
American (AMR)
AF:
0.261
AC:
3992
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
0.253
AC:
878
AN:
3470
East Asian (EAS)
AF:
0.232
AC:
1195
AN:
5156
South Asian (SAS)
AF:
0.264
AC:
1270
AN:
4808
European-Finnish (FIN)
AF:
0.295
AC:
3110
AN:
10544
Middle Eastern (MID)
AF:
0.167
AC:
49
AN:
294
European-Non Finnish (NFE)
AF:
0.319
AC:
21703
AN:
67942
Other (OTH)
AF:
0.256
AC:
541
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1487
2974
4461
5948
7435
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
412
824
1236
1648
2060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.290
Hom.:
2860
Bravo
AF:
0.259
Asia WGS
AF:
0.226
AC:
789
AN:
3478
EpiCase
AF:
0.301
EpiControl
AF:
0.298

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

CYP4F2-related disorder Benign:1
Oct 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.65
CADD
Benign
8.8
DANN
Uncertain
0.99
PhyloP100
2.1
PromoterAI
0.0052
Neutral
Mutation Taster
=93/7
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2074900; hg19: chr19-15996820; COSMIC: COSV50000437; API